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Abstract
HSAF is an antifungal natural product with a new mode of action. A rare bacterial iterative PKS-
NRPS assembles the HSAF skeleton. The biochemical characterization of the NRPS revealed that
the thioesterase (TE) domain possesses the activities of both a protease and a peptide ligase.
Active site mutagenesis, circular dichroism spectra and homology modeling of the TE structure
suggested that the TE may possess uncommon features that may lead to the unusual activities. The
iterative PKS-NRPS is found in all polycyclic tetramate macrolactam gene clusters, and the
unusual activities of the TE may be common to this type of hybrid PKS-NRPS.
HSAF (dihydromaltophilin) is an antifungal metabolite produced by the biological control
agent Lysobacter enzymogenes C3.1 Strain C3 has shown efficacy in control multiple fungal
pathogens infecting wheat and barley.2–4 HSAF exhibits strong activity against a wide range
of fungi and exhibits a novel mode of action.5–7 HSAF is a polycyclic tetramate
macrolactam (PTM) (Figure 1), which is distinct from any existing fungicides.8 One of the
intriguing features of HSAF is that it has two amide bonds that are formed between two
separate polyketide chain and the two amino groups of ornithine.9 This is distinct from other
tetramic acid-containing polyketides, such as equisetin 10, fusarin C 11, tenellin 12 and
cyclopiazonate.13 The tetramate macrolactam formation leads to the release of the two
polyketide chains bound to the hybrid polyketide synthase (PKS)-nonribosomal peptide
synthetase (NRPS) that is responsible for the assembly of the HSAF skeleton.9,14 This
hybrid PKS-NRPS contains nine domains, including a C-terminal thioesterase (TE). The
HSAF structural features and our previous studies 8,9 suggest that the TE domain uses a
carbon nucleophile (carbanion), instead of an oxygen or nitrogen nucleophile as seen in
typical PKS-NRPS, to attack the carbonyl group of the acyl-O-synthase to release the acyl
chain. The determination of the reactions catalyzed by the PKS-NRPS domains could reveal
new insights into the mechanism for the formation of the unusual functionalities.
We previously purified the 4-domain (C-A-PCP-TE, 149 kDa) NRPS that was
heterologously expressed in E. coli.9 To directly show the amide bond formation, we first
performed the 14C-ornithine labeling of C-A-PCP-TE following the established
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methods.15,16 The protein was pre-incubated with Svp, a 4′-phosphopantetheinyl (PPT)
transferase to tether the PPT group to the PCP.17 In the presence of ATP, ornithine was
expected to be recognized by the A domain and loaded to the holo-PCP to form 14C-
aminoacyl-S-PCP. During these assays, we found an unusual phenomenon. As part of the
standard procedure, the protein samples, after the desired reactions, were boiled for 5–10
min before being loaded and analyzed by SDS-PAGE that would be exposed to an X-ray
film. Surprisingly, we found that about 50% of the 149 kDa band disappeared upon 5 min
boiling and concurrently a band at about 300 kDa appeared on the gel (Figure 2A). Other
proteins, such as BSA (66.8 kDa) and lysozyme (14.3 kDa), under the same conditions
remained unchanged. Interestingly, both the 149 and ~300 kDa NRPS bands completely
disappeared when the boiling time was over 15 min. The similar phenomenon was also
observed when the NRPS was co-incubated with other proteins (shown BSA in Figure 2A).
The 66.8 kDa BSA band disappeared upon boiling and new bands (putative oligomers) at
the high mass region appeared. One possible explanation of this phenomenon is that this
NRPS possesses a peptide ligase-like activity as well as a protease-like activity at the
elevated temperature.
Considering the composition of the NRPS, we concluded that the TE domain is most likely
responsible for this unusual activity. To test this idea, we expressed the TE domain in E. coli
and purified the 28.3 kDa protein (Figure S1). When TE was boiled, the 28.3 kDa band
gradually reduced while a band at ~56 kDa gradually increased on SDS-PAGE (Figure 2B).
In addition, the originally sharp 28.3 kDa TE band became smear, implying a partial
degradation/ligation may have taken place. When TE was co-incubated with BSA, the 66.3
kDa BSA band gradually disappeared while the bands at the high mass region appeared
again (Figure 2C–D). In the presence of BSA, the 28.3 kDa TE band was only slightly
decreased. To test if the bands at the high mass region were protein aggregates due to a heat-
denaturation, BSA alone was treated under the same conditions. However, no band
corresponding to those putative oligomers was formed. Furthermore, when the serine
protease inhibitor phenylmethanesulfonylfluoride (PMSF; Figure 2E) was co-incubated with
TE and BSA under the same conditions, the 66.8 kDa BSA band reappeared on the gel. The
BSA reappearance was PMSF concentration-dependent. The effect was also observed in the
presence of other inhibitors such as TPCK and TLCK (data not shown). In addition to BSA,
other proteins (lysozyme and acyl carrier protein 18) exhibited the similar results when co-
incubated with the TE. These results clearly showed that the observed phenomenon is due to
a peptide ligase/protease-like activity of the TE domain, rather than a random aggregation of
the proteins.
The BSA band shifted to higher mass only when the temperature was above 65 °C (Figure
S2). Since the activity is temperature-dependent, we measured the TE’s circular dichroism
spectral changes at different temperatures (Figure S3). From 20 to 100 °C, the content of α-
helices and unordered structures decreased while the β-sheets and turns increased.
Nevertheless, the TE appeared to retain part of its secondary structure even at 100 °C.
Moreover, the secondary structural elements were partly restored when the temperature
gradually shifted from 100 °C back to 20 °C (Figure S3). In agreement with the
observations, the TE maintained the ligase-like activity on SDS-PAGE when it was pre-
heated at 100 °C for 5–15 min and then co-incubated with BSA (Figure S4). To exclude the
possibility that the observed activity is due to a contaminated enzyme, we expressed
surfactin TE and enterobactin TE in E. coli.19–20 Both of the TE domains belong to non-
PTM type NRPS. When these TE domains were purified and tested under the same
conditions as for HSAF TE, no activity was observed (Figure S5).
To further investigate this unusual phenomenon, we analyzed the TE using MS. While the
control protein gave the expected mass, the purified TE did not provide the expected
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molecular mass of 28345 Da, but rather produced a number of minor components over a
broad region (from 26 to 36 kDa). TE belongs to the α/β-hydrolase superfamily which
includes lipases and proteases.14 A conserved catalytic triad, Ser-His-Asp, is present in these
enzymes. We mutated the TE’s active site Ser91 to alanine and expressed the mutant TE-
S91A in E. coli (Figure S1). The purified TE-S91A produced a molecular species of 28329
Da by MS, identical to the calculated mass. Next, we searched for potential self-cleaved
products resulting from the protease activity using LC-MS. Indeed, we detected peptide
fragments in the freshly prepared native TE samples at the room temperature (Figure S6).
The specificity of the cleavage site appears to be the C-terminus of polar amino acids, such
as S, D, R, C, and T. Notably, these fragments were not observed in TE-S91A. Interestingly,
TE-S91A still exhibited the same ligase-like activity as the wild type TE as shown by SDS-
PAGE (Figure S7). To test the possibility that another Ser in this TE may compensate the
mutated Ser91, we generated a second mutant, TE-S119A. Ser119 was chosen because it is
close to Ser91 in TE homology model (see below). This mutant behaved in the same manner
as native TE, with the exception that its activity was only slightly inhibited upon PMSF
treatment (even up to 100 mM) (Figure S8). We then generated a double-mutated TE, TE-
S91A/S119A. Surprisingly, this double mutant behaved just like the wild type on SDS-
PAGE (Figure S8). Finally, a double mutant, TE-R71S/S119A, with the active site Ser91
unchanged, also showed the activity (Figure S8). It appears likely that another Ser or a water
molecule could act as the nucleophile when the mutants exhibited the peptide ligase-like
activity (Figure 3).
The structure of several PKS-NRPS TE domains has been solved.21–25 Our efforts to obtain
an HSAF TE crystal structure have so far been unsuccessful. However, a homology
modeling on known structures suggested that HSAF TE has a typical α/β-hydrolase fold
common to this family of enzyme. Two NRPS TE (fengycin 21 and surfactin TE 22) and two
PKS TE (DEBS 23 and picromycin TE 24) were chosen in the study because they show the
highest sequence similarity to HSAF TE. The predicted secondary structure of HSAF TE
showed the typical α/β-hydrolase fold, with a central 6-stranded β-sheet surrounded by 6
helices (Figure S9). The predicted 3-D structure of HSAF TE well superimposed with the
known TE structures, with Z-score of 16.3–30.4 and RMSD of 1.4–3.3 Å (Figure S10). The
catalytic triad (Ser91-Asp118-His218) of HSAF TE was well positioned in the substrate
pocket and nearly superimposable with the triad of fengycin TE and surfactin TE, except
that Asp118 appeared to deviate from the know structures (Figure S10). Further studies are
needed to determine whether this deviation or any other structural feature of HSAF TE
contributes to the observed unusual activities.
To our knowledge, this is the first example where a TE exhibits both a protease-like activity
and a peptide ligase-like activity. Recently, a tandem TE1-TE2 in the NRPS for lysobactin
biosynthesis, which is also from a species of Lysobacter, was found to have a protease-like
activity.26 The biochemical data presented here provide a foundation for further
investigations to uncover the molecular basis for these unusual activities. HSAF belongs to a
group of emerging polycyclic tetramate macrolactams (PTM), including frontalamides,27
alteramide A,28 cylindramide,29 discodermide,30 ikarugamycin,31 aburatubolactam A,32 and
geodin A.33 This group of metabolites has unique structural features and diverse biological
activities. The biochemical and molecular mechanisms for their biosynthesis remain largely
unclear. Clardy et al. recently showed that PTMs from phylogenetically diverse bacteria
have common biosynthetic origins.27 Within the numerous uncharacterized PTM gene
clusters, a TE is always present at the C-terminus of a hybrid PKS-NRPS. The unusual
activities found in HSAF TE could be a common feature of the PTM-type TE. Finally, the
amide-bond formation/cleavage activity of this TE implies that this terminal domain could
catalyze the formation of one of the two amides in PTM, in addition to the final product
release.
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Figure 1.
Biosynthetic mechanism for the tetramate macrolactam functionalities in HSAF.
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Figure 2.
SDS-PAGE of the 4-domain (C-A-PCP-TE) NRPS and the TE domain to show the peptide
ligase-like activity. (A) NRPS alone or with BSA; (B) TE alone; (C) BSA alone; (D) TE
incubated with BSA; (E) TE incubated with BSA in the presence of serine protease inhibitor
PMSF. The samples were loaded to the gels without boiling or boiled at 100 °C for 5–30
min as indicated.
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Figure 3.
Proposed mechanism for the peptide ligase-like activity observed in HSAF TE and mutant
TE-S91A.
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Unusual Activities of the Thioesterase Domain for the Biosynthesis of the Polycyclic Tetramate 
Macrolactam HSAF in Lysobacter enzymogenes C3 
 
Lili Lou,† Haotong Chen,† Ronald L Cerny,† Yaoyao Li,‡ Yuemao Shen,‡ Liangcheng Du*,† 
†Departments of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68588, USA, and 
‡School of Life Science, Shandong University, Jinan 250100, China 
 
General Materials and Methods. Chemicals used in this study were purchased from Fisher 
Scientific or Sigma. All oligonucleotide primers for PCR were synthesized by Integrated DNA 
Technologies (IDT, Coralville, IA). Plasmid preparation and DNA extraction were carried out 
with Qiagen kits (Valencia, CA), and all other DNA manipulations were carried out according to 
standard methods. The Escherichia coli strain XL Blue was used as the host for general plasmid 
DNA propagation, and cloning vectors were pANT841. 
Expression of HSAF-TE, Srf TE and EntF TE. The 732-bp thioesterase (TE) domain of 
HSAF hybrid PKS/NRPS was amplified by PCR using Pfu DNA polymerase and cosmid COS 
8-1 of Lysobacter enzymogenes C3 as template. The forward primer was P1, and the reverse 
primer was P2 (Table S1). The PCR product was digested with NcoI and BamHI, and then 
ligated into pANT841 that has been linearized with the same enzymes to generate pANT841-TE. 
The plasmid pANT841-TE was sequenced to confirm the fidelity of the TE domain. To express 
the TE domain, the NcoI/BamHI fragment was released from pANT841-TE and ligated into 
pQE60 at the same sites, to generate pQE60-TE. This expression construct was then introduced 
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into E. coli SG13009 (pREP4), which is expected to produce a protein of 256 amino acid 
residues. Single colonies were inoculated in LB at 37 ºC supplemented with 50 µg/ml ampicillin 
and 25 µg/ml kanamycin. When OD600nm reached 0.7, the cultures were cooled for 20 min at 4 
ºC. IPTG (0.5 mM) was added to the cultures, which were allowed to grow for additional 14 h at 
25 ºC. The cells were harvested and resuspended in 20 mM PBS, pH 7.8, containing 5 mM 
imidazole, 500 mM NaCl, 1 mg/mL lysozyme, and 0.5% Triton X-100. The mixture was 
incubated on ice for 30 min, followed by sonication, and centrifugation. The soluble fraction was 
loaded to a Ni-NTA column (Qiagen), and the C-His6-tagged TE (28.3 kDa) was purified by 
using an imidazole step-gradient as instructed by the manufacturer’s protocol. The purity of the 
protein was analyzed by SDS-PAGE, and the fractions containing purified protein was pooled, 
concentrated, and dialyzed against 50 mM PBS, pH 7.8, containing 250 mM NaCl and 15% 
glycerol. Finally the protein solution was frozen in liquid nitrogen and stored at -80 ºC until use. 
To express the two non-PTM TE proteins, Srf TE and EntF TE, we obtained two constructs, Srf 
TE/pET30a and EntF TE/pET30a, which were generous gifts from Prof. Walsh’s group at 
Harvard Medical School. Srf TE and EntF TE were expressed and purified as described.1,2  
Site-directed mutagenesis. The active site Ser91 in the conserved motif “GxSxG” and a 
nearby Ser119 were changed to Ala using the overlap extension PCR method. The primers used 
in the experiments are summarized in Table S1. Primer pairs P1/P4 and P3/P2 were used in the 
TE-S91A generation, and primer pairs P1/P6 and P5/P2 were used in the TE-S119A generation. 
Cosmid COS 8-1 was used as template. For the double mutant TE-S91A/S119A, primer pairs 
P1/P6 and P5/P2 were used, with the plasmid TE-S91A-pANT841 as the template. All mutated 
sites were confirmed by DNA sequencing. Additionally, the sequencing data showed that one of 
the colonies that were supposed to generate the TE-S119A mutant contained a random PCR 
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mutation that changed Arg71 to Ser. This generated an unexpected double mutant TE-
R71S/S119A, which was also expressed and purified and used as a control in the assays. 
LC-MS analysis. The peptide fragments resulting from the protease activity of TE were 
analyzed by LC-MS on a Waters (Micromass) Q-TOF Ultima (Waters; Micromass UK, Beverly, 
MA, USA) and a Shimadzu HPLC system consisting of a SCL-10A controller with two pumps 
(LC-10AT and LC-10AD). A Micro-Tech scientific column (reverse phase, 15 cm × 1.000 mm 
id, P/N mm-15-C4W) was used for separations. The flow rate was 50 μl/min. Solvent A was 
H2O containing 0.1% formic acid; solvent B was acetonitrile containing 0.1% formic acid. The 
gradient was as follows: 0-5 min, 0% B; 5-10 min, 0% B to 20% B gradient; 10-35 min, 20% B 
to 70% B gradient; 35-38 min, 70% B to 85% B gradient; 38-43 min, 85% B; 43-46 min, 85% B 
to 0% B gradient; 46-56 min, 0% B. The mass spectrometer was operated in positive ion mode 
with electrospray ionization. The software Masslynx V3.5 was used in analysis. To measure the 
mass of the intact proteins, samples were analyzed with a Qstar XL system (Applied Biosystems 
Inc., Foster City, CA) using a turbo ion spray source probe source. The analysis was performed 
by loading 100 μL of the protein sample into a 2 mm × 20 mm preconcentration loop filled with 
perfusion material POROS 10 R2 (PerSeptive Biosystems). The salt was removed from the 
protein sample by passing 2 mL of 0.25% formic acid through the preconcentration loop. After 
being desalted, the intact protein was directed to a Micro-Tech Scientific C18 reverse phase 
column. A Shimadzu (SCL-10A) HPLC system (Shimadzu Scientific Instruments, Inc., 
Columbia, MD) was used for gradient elution with a flow rate of 50 μL/min at ambient 
temperature. Analytes of interest were eluted from the column by using gradient elution of 0.3% 
formic acid in H2O (solvent A) and 0.3% formic acid in acetonitrile (solvent B). The percentage 
of solvent B was gradually increased from 10 to 90% with a linear gradient over a time period of 
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10 min followed by washing and an equilibration step. The total run time for each sample was 20 
min. The data were acquired in TOF (time-of-flight) positive ion mode, and the mass range was 
800–1000 amu (atomic mass units). Analyst QS version 1.1 was used to process the data. 
Molecular masses of proteins were generated from several multiply charged peaks using the 
Bayesian Protein Reconstruct option in Bioanalyst Extensions version 1.1.5.  
Circular dichroism Measurements. CD measurements were carried out on a Jasco J-815 
(Japan) equipped with a Jasco PTC-423S/15 Peltier temperature controller under a nitrogen flow 
rate of 10 L/min. All spectra reported in this work had high tension (HT) values on the 
photomultiplier tube below 600 V. Protein concentration was determined by ultraviolet-visible 
absorbance at 280 nm using a molar extinction coefficient of 20130 M−1 cm−1. The protein 
concentration was 7 μM in 5 mM PBS buffer at pH 7.8. Prior to each scan, the background was 
set using the appropriately pH-adjusted solvent (5 mM K2HPO4/KH2PO4, pH7.8). Sample 
solution was placed in a 1-cm path-length strain-free quartz cell, and the spectrum was recorded 
every 0.1 nm from 200 to 260 nm at varying temperatures: 20, 37, 50, 65, 80 and 100 ºC. Each 
spectrum represents the average of three scans. The scanning speed was 100 nm/min, data pitch 
was 0.1-nm increments, the bandwidth was 1 nm, Digital Integration Time was 1 s, the 
accumulation was 3, the scanning resolution was 0.1 nm, and the standard sensitivity was used.  
For the thermal denaturation curves, samples were heated from 20 ºC to 100 ºC at 1.5 ºC/min.  
Deconvolution of the spectra was performed using the program of CDpro.  
In vitro activity assays. In the assays of the peptide ligase-like activity, a 3 μl purified 
enzyme (0.2 mg/ml of C-A-PCP-TE, 1.69 mg/ml of TE, 1.68 mg/ml of TE-S91A, 2.2 mg/ml of 
TE-S119A, 2.14 mg/ml of TE-S91A/S119A, 2.12 mg/ml of TE-R71S/S119A ) was mixed with 3 
μl BSA (2.5 mg/ml). Each sample was boiled for 0-30 min as specified in the individual figures.  
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The samples were added with an equal volume (6 μl) of SDS-PAGE loading buffer and boiled 
for 8 min. After centrifugation at 13200 rpm for 5 min, the supernatant of each of the samples 
was collected and analyzed by SDS-PAGE (12%). In the same way, fumonisin ACP 3 and 
lysosome were also tested with HSAF TE. In experiments testing TE’s protease-like activity, 
four different protease inhibitors (from Sigma), PMSF (1.0 mM, 2.5 mM, 25 mM), leupeptin 
(175 µm, 315 µm,1.75 mM), TPCK (100 µm) , and TLCK (100 µm), were added to the samples 
prior to the 0-30 min boiling. A control without inhibitor was tested simultaneously. 
Sequence alignment and homology modeling. A template search was first performed through 
the BLAST programs. Two NRPS TE (fengycin TE and surfactin TE) and two PKS TE (DEBS 
TE and picromycin TE) were chosen to do multiple sequence alignment as they showed the 
highest sequence similarity with HSAF TE. Sequence alignments were generated using 
CLUSTALW 2,4 and secondary structure annotations for HSAF TE were generated using Espript 
2.2.5 Homology modeling for 3D structure of HSAF TE was performed using MODELLER 
Version 9v7.6 Alignment file for MODELLER was prepared by CLUSTALW. Molecular 
visualization program VMD 1.8.6 was used for displaying, animating, and analyzing the 
structures. Protein 3D structure alignments were done using the DaliLite Pairwise comparison. 
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Table S1: Primers used in this study 
P1 (TE-NcoI-Fr) 5'-GTC ACC ATG GGA AAG ACG GTG GAG GCG ATC AGC-3' 
P2 (TE-BamHI-Rv) 5'-TTA GGA TCC GGC GAC ATG GCC CGT CTC CCC-3' 
P3 (TE-S91A-Fr) 5'-CTG TTC GGC TAC GCG CTC GGC GGC-3'  
P4 (TE-S91A-Rv) 5'-GTT GCC GCC GAG CGC GTA GCC GAA CAG -3' 
P5 (TE-S119A-Fr) 5'-GTG GTC ATC ATG GAT GCC TAC CGC-3' 
P6 (TE-S119A-Rv) 5'-TTC CGG GAT GCG GTA GGC ATC CAT GAT-3'  
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Figure S1. Expression and purification of the TE domain. (A) The wild type TE. Lane-1, total 
proteins before IPTG induction; lane-2, total proteins after IPTG induction; lane-3, soluble 
proteins; lane-4, purified TE-domain; lane-5, markers. (B) The TE-S91A mutant. Lane-1, 
markers; lane-2-4, eluted fractions from a Ni-NTA column. 
8 
 
 
 
Figure S2. SDS-PAGE of the TE domain incubated with BSA and treated at different 
temperatures for different periods of time. 
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A 
 
 
Temp (℃) helix sheet Turn Unrd 
20 0.183 0.302 0.207 0.309 
37 0.156 0.317 0.216 0.311 
50 0.091 0.363 0.212 0.334 
65 0.064 0.434 0.214 0.288 
80 0.064 0.433 0.239 0.264 
100 0.07 0.432 0.233 0.265 
 
B 
 
Temp (℃) helix sheet Turn Unrd 
100 0.07 0.432 0.233 0.265 
80 0.069 0.423 0.227 0.282 
65 0.068 0.429 0.217 0.285 
50 0.077 0.377 0.227 0.318 
37 0.097 0.357 0.216 0.33 
20 0.098 0.349 0.213 0.338 
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Figure S3. Far-UV circular dichroism spectra of HSAF TE and secondary structure analysis. CD 
measurements were carried out on a Jasco J-815 equipped with a Jasco PTC-423S/15 Peltier 
temperature controller. The secondary structure analysis was done by software CDPro.  
A.  CD spectra of TE (in pH 7.8 PBS buffer) with increasing temperatures (from 20 ºC to 100 ºC) 
and the predicted secondary structure elements.  Note: Unrd, unordered structure. 
B. CD spectra of TE (in pH 7.8 PBS buffer) with decreasing temperatures (from 100 ºC to 20 ºC) 
and the predicted secondary structure elements. 
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Figure S4. SDS-PAGE of the TE domain after it was pre-boiled for 5-15 min and then co-heated 
with BSA for 0, 5, or 12 min.  
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B 
 
Figure S5. Expression, purification and activity test of two non-PTM TE domains.  
A. Srf TE. Lane-1, total proteins before IPTG induction; lane-2, total proteins after IPTG 
induction; lane-3, soluble proteins; lane-4, purified Srf TE; M, size markers; the next four lanes, 
Srf TE alone boiled for 0,  5, 15, 30 min, respectively; the last four lanes, Srf TE with BSA 
boiled for 0,  5, 15, 30 min, respectively.  
B. EntF TE. Lane-1, total proteins before IPTG induction; lane-2, total proteins after IPTG 
induction; lane-3, soluble proteins; M, size markers; the next four lanes, EntF TE alone boiled 
13 
 
for 0,  5, 15, 30 min, respectively; the last four lanes, EntF TE with BSA boiled for 0,  5, 15, 30 
min, respectively. 
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Figure S6. Peptide fragments identified by LC-MS resulted from self-cleavage of HSAF TE. The 
cleavage sites and corresponding mass are indicated on the amino acid sequence under each of 
the spectra. 
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Figure S7. SDS-PAGE of TE-S91A mutant incubated with BSA with or without the protease inhibitor 
PMSF. Lane 1-4, TE-S91A + BSA, no inhibitor, boiled for 0,  5, 15, 30 min, respectively; lane 5, TE-
S91A + BSA, no boiling; lane 6-9, TE-S91A + BSA + PMSF boiled for 12 min, with 0, 1, 2.5, 25 mM 
PMSF, respectively. 
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Figure S8. SDS-PAGE of TE-S119A mutant, TE-S91A/S119A double mutant, and TE-R71S/S119A 
double mutant incubated with BSA with or without the protease inhibitor PMSF. Lane 1, TE-S119A, no 
boiling; lane 2, TE-S119A, boiled 15 min; lane 3, TE-S119A + BSA, no boiling; lane 4, TE-S119A + 
BSA, boiled 15 min; lane 5, TE-S119A + BSA + 100 mM PMSF, boiled 15 min; lane 6, markers; lane 7, 
TE-S91A/S119A, no boiling; lane 8, TE-S91A/S119A, boiled 15 min; lane 9, TE-S91A/S119A + BSA, 
no boiling; lane 10, TE-S91A/S119A + BSA, boiled 15 min; lane 11, TE-S91A/S119A + BSA + 100 mM 
PMSF, boiled 15 min;  lane 12, TE-R71S/S119A, no boiling; lane 13, TE-R71S/S119A, boiled 15 min;  
lane 14, TE-R71S/S119A + BSA, boiled 15 min; lane 15, TE-R71S/S119A + BSA + 100 mM PMSF, 
boiled 15 min. 
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Figure S9. Primary sequence alignment of several TEs and secondary structure prediction of 
HSAF TE. PicTE, picromycin PKS TE;7 DEBS, 6-deoxyerythronolide B synthase TE;8 FenTE, 
fengycin NRPS TE;9 SurTE, surfactin NRPS TE.10 Invariant residues are in white with a red 
background, other conserved sites are in red. Espript 2.2 was used to generate secondary 
structure annotations for HSAF TE. 
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Figure S10. The structure of HSAF TE derived from homology modeling on known TE structures. 
A. The three-dimensional structure superimposition of TEs. Fengycin TE (orange, PDB entry 
2CB9), surfactin TE (purple, PDB entry 1jmkc), and HSAF TE (green). B. The well conserved 
catalytic triad, shown in ball-and-stick, within the substrate binding pocket of the TE structures. 
C. Superimposition of the active site to show the deviation of HSAF TE’s Asp from the known 
structures. FenTE (orange), SrfTE (purple), HSAF TE (green). D-E. Active site comparison 
between fengycin TE and HSAF TE. Note that the similar H-bond distance between the hydroxyl 
of serine and the NE2 atom of histidine (3.08Å for FenTE and 3.38Å for HSAF TE).
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